Serum and blister-fluid elevation and decreased epidermal content of high-mobility group box 1 protein in drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis



Carr, DF, Wang, C-W, Bellon, T, Ressel, L ORCID: 0000-0002-6614-1223, Nwikue, G, Shrivastava, V, Bergfeld, W, Jorgensen, AL ORCID: 0000-0002-6977-9337, Chung, W-H and Pirmohamed, M ORCID: 0000-0002-7534-7266
(2019) Serum and blister-fluid elevation and decreased epidermal content of high-mobility group box 1 protein in drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. BRITISH JOURNAL OF DERMATOLOGY, 181 (1). pp. 166-174.

[img] Text
Accepted manuscript.pdf - Author Accepted Manuscript

Download (575kB)

Abstract

<h4>Background</h4>High-mobility group box 1 (HMGB1) is a damage-associated molecular-pattern protein. Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) are serious, immune-mediated skin-blistering conditions.<h4>Objectives</h4>To determine serum and/or blister-fluid total HMGB1 levels in SJS/TEN cohorts, and HMGB1 expression in formalin-fixed, paraffin-embedded (FFPE) SJS/TEN skin vs. healthy and maculopapular exanthema (MPE) skin. Methods Serum HMGB1 was quantified in Malawian nevirapine-induced hypersensitivity, Taiwanese SJS/TEN and Spanish SJS/TEN cohorts. FFPE skin (healthy skin, MPE, SJS/TEN) was stained and assessed for HMGB1 expression.<h4>Results</h4>Serum total HMGB1 was not significantly elevated in patients with nevirapine-induced SJS/TEN (3·98 ± 2·17 ng mL<sup>-1</sup> ), MPE (3·92 ± 2·75 ng mL<sup>-1</sup> ) or drug reaction with eosinophilia and systemic symptoms (4·73 ± 3·00 ng mL<sup>-1</sup> ) vs. tolerant controls (2·97 ± 3·00 ng mL<sup>-1</sup> ). HMGB1 was significantly elevated in Taiwanese patients with SJS/TEN, highest during the acute phase (32·6 ± 26·6 ng mL<sup>-1</sup> ) vs. the maximal (19·7 ± 23·2 ng mL<sup>-1</sup> ; P = 0·007) and recovery (24·6 ± 25·3 ng mL<sup>-1</sup> ; P = 0·027) phases. In blister fluid from Spanish patients with SJS/TEN, HMGB1 (486·8 ± 687·9 ng mL<sup>-1</sup> ) was significantly higher than in serum (8·8 ± 7·6 ng mL<sup>-1</sup> ; P <0·001). Preblistered SJS/TEN skin showed decreased epidermal nuclear HMGB1 expression in upper epidermis vs. healthy or MPE skin but retained basal/suprabasal expression.<h4>Conclusions</h4>Epidermal HMGB1 expression was decreased in SJS/TEN skin. Retained basal/suprabasal epidermal HMGB1 expression may exacerbate localized injury in SJS/TEN.

Item Type: Article
Uncontrolled Keywords: Epidermis, Humans, Stevens-Johnson Syndrome, Blister, HMGB1 Protein, Biopsy, Prospective Studies, Adult, Aged, Middle Aged, Female, Male, Young Adult, Biomarkers
Depositing User: Symplectic Admin
Date Deposited: 07 Jan 2019 10:47
Last Modified: 19 Jan 2023 01:08
DOI: 10.1111/bjd.17610
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3030798